Home / Drug shortages / Carbamazepine Capsule, Extended Release

Carbamazepine Capsule, Extended Release — FDA Drug Shortage

To Be Discontinued — Takeda Pharmaceuticals USA Inc.

The FDA lists a drug shortage record for Carbamazepine Capsule, Extended Release (capsule, extended release) from Takeda Pharmaceuticals USA Inc. with status To Be Discontinued. The shortage was first posted on 12/19/2025.

Shortage Details

Status
To Be Discontinued
Company
Takeda Pharmaceuticals USA Inc.
Package NDC
54092-172-12
Dosage Form
Capsule, Extended Release
Presentation
Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12)
Initial Posting
12/19/2025
Revised Date

FDA data resources